Atlas Trials

To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects

Clinical trial NCT07371065 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07371065
Sponsor
Luye Pharma Group Ltd.
Status
ENROLLING_BY_INVITATION
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2025-10-28
Primary completion
2026-04-30
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.